BackPeak Bio- Warrants (05/01/2026) Overview

Peak Bio- Warrants (05/01/2026) Net Income

Peak Bio- Warrants (05/01/2026)'s net income is $1.7M, below the sector sector average of $98M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$301.00
↑ 99.99% YoY

As of Jun 2025

Annual Net Income (TTM)

$1.71M
↑ 202.68% YoY

Trailing 12 months ending Jun 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Peak Bio- Warrants (05/01/2026) (PKBOW) FAQ

The latest net income for PKBOW is $1.7M as of June 2025. That compares with $-1.7M in the prior-year period — up 202.7% year over year. That is below the sector sector average of $98M. Investors often review this figure alongside Peak Bio- Warrants (05/01/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PKBOW's net income moved from $-1.7M to $1.7M — a 202.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Peak Bio- Warrants (05/01/2026)'s operating scale or balance-sheet position.

Against its sector companies, PKBOW currently prints $1.7M for net income, while the sector average sits near $98M. That is roughly 98.2% below the sector mean. Large gaps often invite a closer look at Peak Bio- Warrants (05/01/2026)'s growth, margins, and balance sheet.

A net income figure of $1.7M for PKBOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $98M. Explore the charts below for those layers of context.

After noting PKBOW's net income ($1.7M), review year-over-year change from $-1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.